LINC02126

Across TCGA pan-cancer cohorts, LINC02126 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02126’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02126 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02126 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, STAD, and LUSC are the cancer types where LINC02126 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02126 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	III,IV	−0.602	<.001	10	view →
STAD	All	II,III,IV	+0.236	<.001	10	view →
LUSC	Male	III,IV	−1.567	<.001	8	view →
COAD	All	II,III,IV	+0.198	.001	7	view →
KICH	All	All	−0.191	<.001	7	view →
BRCA	Female	All	+0.296	<.001	6	view →
HNSC	Female	All	+0.109	.028	4	view →
PAAD	Male	All	−0.755	.013	2	view →
UCEC	All	All	−0.466	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC02126–LUAD

Open the LUAD breakdown →